Navidea Biopharmaceuticals Inc (NAVB) stock is lower by -39.16% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives NAVB stock a score of 30 out of a possible 100.
That rank is mainly influenced by a fundamental score of 0. NAVB stock has a mean target price of $5.00. This means analysts expect the stock to add 395.05% over the next 12 months. NAVB's rank also includes a short-term technical score of 31. The long-term technical score for NAVB is 60.
NAVB has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on NAVB!
Navidea Biopharmaceuticals Inc (NAVB) stock is up 7.07% while the S&P 500 has risen 2.74% as of 2:36 PM on Thursday, Apr 28. NAVB has risen $0.07 from the previous closing price of $0.94 on volume of 66,983 shares. Over the past year the S&P 500 has risen 2.76% while NAVB is lower by -39.16%. NAVB lost -$0.40 per share in the over the last 12 months.
Click Here to get the full Stock Report for Navidea Biopharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
